{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T23:10:53Z","timestamp":1789600253362,"version":"build-2803163510"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2015,9,30]],"date-time":"2015-09-30T00:00:00Z","timestamp":1443571200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,9,30]],"date-time":"2015-09-30T00:00:00Z","timestamp":1443571200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Antibiot"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1038\/ja.2015.91","type":"journal-article","created":{"date-parts":[[2015,9,30]],"date-time":"2015-09-30T06:21:37Z","timestamp":1443594097000},"page":"319-326","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Non-antibiotic 12-membered macrolides: design, synthesis and biological evaluation in a cigarette-smoking model"],"prefix":"10.1038","volume":"69","author":[{"given":"Akihiro","family":"Sugawara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Shima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akito","family":"Sueki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyasu","family":"Hirose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidehito","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayato","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Hanaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoko S","family":"Akagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"\u014cmura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiaki","family":"Sunazuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,9,30]]},"reference":[{"key":"BFja201591_CR1","doi-asserted-by":"crossref","unstructured":"Sunazuka, T., Omura, S., Iwasaki, S. & \u014cmura, S. in Macrolide Antibiotics. Chemistry, Biology, and Practice. 2nd edn, (ed. \u014cmura S) Ch. 3, 99\u2013180 (Academic press, California, 2002.","DOI":"10.1016\/B978-012526451-8\/50004-7"},{"key":"BFja201591_CR2","first-page":"G688","volume":"247","author":"Z Itoh","year":"1984","unstructured":"Itoh, Z., Nakaya, M., Suzuki, H., Arai, H. & Wakabayashi, K. Erythromycin mimics exogenous motilin in gastrointestinal contractile activity in the dog. Am. J. Physiol. 247, G688\u2013G694 (1984).","journal-title":"Am. J. Physiol."},{"key":"BFja201591_CR3","doi-asserted-by":"crossref","unstructured":"Inatomi, N., Sato, F., Itoh, Z. & \u014cmura, S. in Macrolide Antibiotics. Chemistry, Biology, and Practice 2nd edn. 2nd edn, (ed. \u014cmura S) Ch. 11, 501\u2013532 (Academic press, California, 2002.","DOI":"10.1016\/B978-012526451-8\/50012-6"},{"key":"BFja201591_CR4","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1111\/bph.12077","volume":"168","author":"J Broad","year":"2013","unstructured":"Broad, J. & Sanger, G. J. The antibiotic azithromycin is a motilin receptor agonist in human stomach: comparison with erythromycin. Br. J. Pharmacol. 168, 1859\u20131867 (2013).","journal-title":"Br. J. Pharmacol."},{"key":"BFja201591_CR5","first-page":"632","volume":"25","author":"S Kudoh","year":"1987","unstructured":"Kudoh, S. et al. Clinical effect of low-dose long-term erythromycin chemotherapy on diffuse panbronchiolitis. Jpn. J. Thorac. Dis. 25, 632\u2013642 (1987) (in Japanese with English abstract).","journal-title":"Jpn. J. Thorac. Dis."},{"key":"BFja201591_CR6","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1164\/ajrccm.157.6.9710075","volume":"157","author":"S Kudoh","year":"1998","unstructured":"Kudoh, S., Azuma, A., Yamamoto, M., Izumi, T. & Ando, M. Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin. Am. J. Respir. Crit. Care Med. 157, 1829\u20131832 (1998).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"BFja201591_CR7","unstructured":"Kudoh, S. et al in Macrolide Antibiotics. Chemistry, Biology, and Practice. 2nd edn, (ed. \u014cmura S) Ch. 12, 533\u2013570 (Academic press, California, 2002."},{"key":"BFja201591_CR8","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1093\/jac\/dkh519","volume":"55","author":"GW Amsden","year":"2005","unstructured":"Amsden, G. W. Anti-inflammatory effects of macrolides\u2013an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions? J. Antimicrob. Chemother. 55, 10\u201321 (2005).","journal-title":"J. Antimicrob. Chemother."},{"key":"BFja201591_CR9","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.7164\/antibiotics.38.1631","volume":"38","author":"S \u014cmura","year":"1985","unstructured":"\u014cmura, S. et al. Gastrointestinal motor-stimulating activity of macrolide antibiotics and the structure-activity relationship. J. Antibiot. 38, 1631\u20131632 (1985).","journal-title":"J. Antibiot."},{"key":"BFja201591_CR10","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1021\/jm00394a001","volume":"30","author":"S \u014cmura","year":"1987","unstructured":"\u014cmura, S. et al. Macrolides with gastrointestinal motor stimulating activity. J. Med. Chem. 30, 1941\u20131943 (1987).","journal-title":"J. Med. Chem."},{"key":"BFja201591_CR11","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.1248\/cpb.37.2687","volume":"37","author":"K Tsuzuki","year":"1989","unstructured":"Tsuzuki, K. et al. Motilides, macrolides with gastrointestinal motor stimulating activity. I. O-Substituted and tertiary N-substituted derivatives of 8,9-anhydroerythromycin A 6,9-hemiacetal. Chem. Pharm. Bull. 37, 2687\u20132700 (1989).","journal-title":"Chem. Pharm. Bull."},{"key":"BFja201591_CR12","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.1248\/cpb.37.2701","volume":"37","author":"T Sunazuka","year":"1989","unstructured":"Sunazuka, T. et al. Motilides, macrolides with gastrointestinal motor stimulating activity. II. Quaternary N-substituted derivatives of 8,9-anhydroerythromycin A 6,9-hemiacetal and 9, 9-dihydroerythromycin A 6, 9-epoxide. Chem. Pharm. Bull. 37, 2701\u20132709 (1989).","journal-title":"Chem. Pharm. Bull."},{"key":"BFja201591_CR13","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1378\/chest.122.6.2137","volume":"122","author":"Y Li","year":"2002","unstructured":"Li, Y. et al. Fourteen-membered ring macrolides inhibit vascular cell adhesion molecule 1 messenger RNA induction and leukocyte migration: role in preventing lung injury and fibrosis in bleomycin-challenged mice. Chest. 122, 2137\u20132145 (2002).","journal-title":"Chest."},{"key":"BFja201591_CR14","doi-asserted-by":"publisher","first-page":"2986","DOI":"10.1128\/AAC.49.7.2986-2989.2005","volume":"49","author":"H Abdelghaffar","year":"2005","unstructured":"Abdelghaffar, H., Babin-Chevaye, C. & Labro, M. T. The macrolide roxithromycin impairs NADPH oxidase activation and alters translocation of its cytosolic components to the neutrophil membrane in vitro. Antimicrob. Agents Chemother. 49, 2986\u20132989 (2005).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFja201591_CR15","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1093\/jac\/dkf008","volume":"49","author":"T Kikuchi","year":"2002","unstructured":"Kikuchi, T. et al. Clarithromycin suppresses lipopolysaccharide-induced interleukin-8 production by human monocytes through AP-1 and NF-\u03baB transcription factors. J. Antimicrob. Chemother. 49, 745\u2013755 (2002).","journal-title":"J. Antimicrob. Chemother."},{"key":"BFja201591_CR16","doi-asserted-by":"publisher","first-page":"80","DOI":"10.7164\/antibiotics.47.80","volume":"47","author":"N Keicho","year":"1994","unstructured":"Keicho, N., Kudoh, S., Yotsumoto, H. & Akagawa, K. S. Erythromycin promotes monocyte to macrophage differentiation. J. Antibiot. 47, 80\u201389 (1994).","journal-title":"J. Antibiot."},{"key":"BFja201591_CR17","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.7164\/antibiotics.46.1406","volume":"46","author":"N Keicho","year":"1993","unstructured":"Keicho, N., Kudoh, S., Yotsumoto, H. & Akagawa, K. S. Antilymphocytic activity of erythromycin distinct from that of FK506 or cyclosporin A. J. Antibiot. 46, 1406\u20131413 (1993).","journal-title":"J. Antibiot."},{"key":"BFja201591_CR18","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1183\/09031936.01.17303600","volume":"17","author":"T Takahashi","year":"2001","unstructured":"Takahashi, T. et al. Erythromycin attenuates an experimental model of chronic bronchiolitis via augmenting monocyte chemoattractant protein-1. Eur. Respir. J. 17, 360\u2013367 (2001).","journal-title":"Eur. Respir. J."},{"key":"BFja201591_CR19","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S0022-3565(24)29389-7","volume":"298","author":"M Tsurita","year":"2001","unstructured":"Tsurita, M. et al. Early augmentation of interleukin (IL)-12 level in the airway of mice administered orally with clarithromycin or intranasally with IL-12 results in alleviation of influenza infection. J. Pharmacol. Exp. Ther. 298, 362\u2013368 (2001).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BFja201591_CR20","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1128\/AAC.49.6.2372-2377.2005","volume":"49","author":"M Bosnar","year":"2005","unstructured":"Bosnar, M., Kelneric, Z., Munic, V., Erakovic, V. & Parnham, M. J. Cellular uptake and efflux of azithromycin, erythromycin, clarithromycin, telithromycin, and cethromycin. Antimicrob. Agents Chemother. 49, 2372\u20132377 (2005).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFja201591_CR21","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1164\/ajrccm.157.3.9703098","volume":"157","author":"K Sato","year":"1998","unstructured":"Sato, K. et al. Therapeutic effect of erythromycin on influenza virus-induced lung injury in mice. Am. J. Respir. Crit. Care Med. 157, 853\u2013857 (1998).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"BFja201591_CR22","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jdermsci.2003.11.002","volume":"34","author":"H Takahashi","year":"2004","unstructured":"Takahashi, H. et al. Roxithromycin decreases ultraviolet B irradiation-induced reactive oxygen intermediates production and apoptosis of keratinocytes. J. Dermatol. Sci. 34, 25\u201333 (2004).","journal-title":"J. Dermatol. Sci."},{"key":"BFja201591_CR23","doi-asserted-by":"publisher","first-page":"5645","DOI":"10.1158\/1078-0432.CCR-05-0652","volume":"11","author":"S Ueno","year":"2005","unstructured":"Ueno, S. et al. Roxithromycin inhibits constitutive activation of nuclear factor \u03baB by diminishing oxidative stress in a rat model of hepatocellular carcinoma. Clin. Cancer Res. 11, 5645\u20135650 (2005).","journal-title":"Clin. Cancer Res."},{"key":"BFja201591_CR24","doi-asserted-by":"publisher","first-page":"4359","DOI":"10.1021\/jo00228a038","volume":"52","author":"HA Kirst","year":"1987","unstructured":"Kirst, H. A., Wind, J. A. & Paschal, J. W. Synthesis of ring-contracted derivatives of erythromycin. J. Org. Chem. 52, 4359\u20134362 (1987).","journal-title":"J. Org. Chem."},{"key":"BFja201591_CR25","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/ja.2005.11","volume":"58","author":"K Yoshida","year":"2005","unstructured":"Yoshida, K. et al. Macrolides with promotive activity of monocyte to macrophage differentiation. J. Antibiot. 58, 79\u201381 (2005).","journal-title":"J. Antibiot."},{"key":"BFja201591_CR26","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.1016\/j.bmcl.2006.01.079","volume":"16","author":"H Gouda","year":"2006","unstructured":"Gouda, H. et al. Three-dimensional solution structure of EM703 with potent promoting activity of monocyte-to-macrophage differentiation. Bioorg. Med. Chem. Lett. 16, 2496\u20132499 (2006).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"BFja201591_CR27","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1465-9921-7-16","volume":"7","author":"YJ Li","year":"2006","unstructured":"Li, Y. J. et al. EM703 improves bleomycin-induced pulmonary fibrosis in mice by the inhibition of TGF-beta signaling in lung fibroblasts. Respir. Res. 7, 16 (2006).","journal-title":"Respir. Res."},{"key":"BFja201591_CR28","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1128\/AAC.48.5.1581-1585.2004","volume":"48","author":"M Desaki","year":"2004","unstructured":"Desaki, M. et al. Molecular mechanisms of anti-inflammatory action of erythromycin in human bronchial epithelial cells: possible role in the signaling pathway that regulates nuclear factor-kappaB activation. Antimicrob. Agents Chemother. 48, 1581\u20131585 (2004).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFja201591_CR29","doi-asserted-by":"publisher","first-page":"12509","DOI":"10.1073\/pnas.0805504105","volume":"105","author":"I Komuro","year":"2008","unstructured":"Komuro, I. et al. Erythromycin derivatives inhibit HIV-1 replication in macrophages through modulation of MAPK activity to induce small isoforms of C\/EBP\u03b2. Proc. Natl Acad. Sci. USA 105, 12509\u201312514 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFja201591_CR30","doi-asserted-by":"publisher","first-page":"3373","DOI":"10.1016\/j.bmcl.2011.04.004","volume":"21","author":"A Sugawara","year":"2011","unstructured":"Sugawara, A. et al. Novel 12-membered non-antibiotic macrolides from erythromycin A; EM900 series as novel leads for anti-inflammatory and\/or immunomodulatory agents. Bioorg. Med. Chem. Lett. 21, 3373\u20133376 (2011).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"BFja201591_CR31","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/ja.2012.51","volume":"65","author":"A Sugawara","year":"2012","unstructured":"Sugawara, A. et al. Novel 12-membered non-antibiotic macrolides, EM900 series with anti-inflammatory and\/or immunomodulatory activity; Synthesis, structure activity-relationships and in vivo study. J. Antibiot. 65, 487\u2013490 (2012).","journal-title":"J. Antibiot."},{"key":"BFja201591_CR32","doi-asserted-by":"publisher","first-page":"3104","DOI":"10.1021\/ja01616a051","volume":"77","author":"EH Flynn","year":"1955","unstructured":"Flynn, E. H., Murphy, H. W. & McMahon, R. E. Erythromycin II. Des-N-methylerythromycin and N-methyl-C14-erythromycin. J. Am. Chem. Soc. 77, 3104\u20133106 (1955).","journal-title":"J. Am. Chem. Soc."},{"key":"BFja201591_CR33","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1021\/jm00276a017","volume":"15","author":"PH Jones","year":"1972","unstructured":"Jones, P. H., Perun, T. J., Rowley, E. K. & Baker, E. J. Chemical modifications of erythromycin antibiotics. 3. Synthesis of 4\u201d and 11 esters of erythromycin A and B. J. Med. Chem. 15, 631\u2013634 (1972).","journal-title":"J. Med. Chem."},{"key":"BFja201591_CR34","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/nrd1502","volume":"3","author":"A Raja","year":"2004","unstructured":"Raja, A., Lebbos, J. & Kirkpatrick, P. Telithromycin. Nat. Rev. Drug Discov. 3, 733\u2013734 (2004).","journal-title":"Nat. Rev. Drug Discov."},{"key":"BFja201591_CR35","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1159\/000334339","volume":"88","author":"K Otsu","year":"2011","unstructured":"Otsu, K. et al. Effects of a novel nonantibiotic macrolide, EM900, on cytokine and mucin gene expression in a human airway epithelial cell line. Pharmacology 88, 327\u2013332 (2011).","journal-title":"Pharmacology"},{"key":"BFja201591_CR36","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.bbadis.2003.09.004","volume":"1639","author":"P Maderna","year":"2003","unstructured":"Maderna, P. & Godson, C. Phagocytosis of apoptotic cells and the resolution of inflammation. Biochimica. et. Biophysica. Acta 1639, 141\u2013151 (2003).","journal-title":"Biochimica. et. Biophysica. Acta"},{"key":"BFja201591_CR37","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1164\/ajrccm.163.5.2101039","volume":"163","author":"RA Pauwels","year":"2001","unstructured":"Pauwels, R. A., Buist, A. S., Calverley, P. M., Jenkins, C. R. & Hurd, S. S. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI\/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) workshop summary. Am. J. Respir. Crit. Care Med. 163, 1256\u20131276 (2001).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"BFja201591_CR38","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1053\/rmed.2000.0960","volume":"95","author":"D Loppow","year":"2001","unstructured":"Loppow, D. et al. In patients with chronic bronchitis a four week trial with inhaled steroids does not attenuate airway inflammation. Respir. Med. 95, 115\u2013121 (2001).","journal-title":"Respir. Med."},{"key":"BFja201591_CR39","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1164\/ajrccm.157.5.9709032","volume":"157","author":"TA Seemungal","year":"1998","unstructured":"Seemungal, T. A. et al. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care. Med. 157, 1418\u20131422 (1998).","journal-title":"Am. J. Respir. Crit. Care. Med."},{"key":"BFja201591_CR40","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1164\/rccm.200806-905OC","volume":"179","author":"Y Nakanishi","year":"2009","unstructured":"Nakanishi, Y. et al. Clarithromycin prevents smoke-induced emphysema in mice. Am. J. Respir. Crit. Care. Med. 179, 271\u2013278 (2009).","journal-title":"Am. J. Respir. Crit. Care. Med."},{"key":"BFja201591_CR41","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1056\/NEJMoa1104623","volume":"365","author":"RK Albert","year":"2011","unstructured":"Albert, R. K. et al. Azithromycin for prevention of exacerbations of COPD. N. Engl. J. Med. 365, 689\u2013698 (2011).","journal-title":"N. Engl. J. Med."},{"key":"BFja201591_CR42","doi-asserted-by":"publisher","first-page":"188S","DOI":"10.1378\/chest.121.5_suppl.188S","volume":"121","author":"JL Wright","year":"2002","unstructured":"Wright, J. L. & Churg, A. A model of tobacco smoke-induced airflow obstruction in the guinea pig. Chest 121, 188S\u2013191S (2002).","journal-title":"Chest"},{"key":"BFja201591_CR43","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1164\/rccm.200411-1549OC","volume":"172","author":"PA Martorana","year":"2005","unstructured":"Martorana, P. A., Beume, R., Lucattelli, M., Wollin, L. & Lungarella, G. Roflumilast fully prevents emphysema in mice chronically exposed to cigarette smoke. Am. J. Respir. Crit. Care Med. 172, 848\u2013853 (2005).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"BFja201591_CR44","unstructured":"National Committee for Clinical Laboratory Standards Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals. Approved standard M31-A (NCCLS, Wayne, PA, USA, 1999."}],"container-title":["The Journal of Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ja201591.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ja201591","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ja201591.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T21:34:01Z","timestamp":1748640841000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ja201591"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,30]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["BFja201591"],"URL":"https:\/\/doi.org\/10.1038\/ja.2015.91","relation":{},"ISSN":["0021-8820","1881-1469"],"issn-type":[{"value":"0021-8820","type":"print"},{"value":"1881-1469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,30]]},"assertion":[{"value":"2 April 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}